There are 2934 resources available
5191 - Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): First Results from the RADICALS RT Randomised Controlled Trial (RCT) [NCT00541047]
Presenter: Chris Parker
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
2508 - Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis
Presenter: Claire Vale
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Proffered Paper – Genitourinary tumours, prostate - Invited Discussant LBA48_PR and LBA49_PR
Presenter: Gert De Meerleer
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Slides
Webcast
Introduction
Presenter: Dirk De Ruysscher
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Nutrition before and during CCRT, including treatment and prevention of anorexia
Presenter: Jann Arends
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Neurological complications of immunotherapy
Presenter: Matthias Preusser
Session: CNS complications and management in systemic cancer patients
Resources:
Slides
Webcast
The value of PD-L1 as a biomarker beyond lung cancers
Presenter: Kevin Harrington
Session: Current markers in immunotherapy
Resources:
Slides
Webcast
Targeting the microenvironment
Presenter: Florent Petitprez
Session: Current markers in immunotherapy
Resources:
Slides
Webcast
Ex-vivo and 3D models: From mice to men
Presenter: Jos Jonkers
Session: Preclinical models and imaging to guide clinical therapy
Resources:
Slides
Webcast
Imaging of the immune system
Presenter: Tony Lahoutte
Session: Preclinical models and imaging to guide clinical therapy
Resources:
Slides
Webcast